Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
4.320
+0.140 (3.35%)
At close: Apr 28, 2026, 4:00 PM EDT
4.370
+0.050 (1.16%)
After-hours: Apr 28, 2026, 6:42 PM EDT
Evaxion Market Cap
Evaxion has a market cap or net worth of $36.03 million as of April 28, 2026. Its market cap has increased by 322.52% in one year.
Market Cap
36.03M
Enterprise Value
20.30M
1-Year Change
322.52%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $36.03M, a decrease of -81.23%. That is a compound annual growth rate of -27.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 34.86M | -12.37% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 36.11M |
| Palatin Technologies | 35.53M |
| Grace Therapeutics | 34.35M |
| Skye Bioscience | 34.07M |
| Pluri | 33.62M |
| IGC Pharma | 32.72M |
| Boundless Bio | 32.49M |
| Outlook Therapeutics | 32.33M |